[1 per cent ubretid in glaucoma therapy].
D002219:Carbamates / Q000008:administration & dosage / Q000009:adverse effects; D005901:Glaucoma / Q000188:drug therapy*; D006801:Humans; D007429:Intraocular Pressure; D011726:Pyridinium Compounds / Q000008:administration & dosage* / Q000009:adverse effects; D014065:Tonometry, Ocular
D002219:Carbamates; D011726:Pyridinium Compounds
1 proz. Ubretid in der Glaukomtherapie.